Back to search
Still´s Disease
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Still´s Disease trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Still´s Disease trials you may qualify forThe study is a phase II trial designed to evaluate the clinical efficacy, safety, and tolerability of MAS825 in pediatric and adult participants with Still's di…
The purpose of this study is to compare the efficacy and safety of firsekibart versus anakinra in patients with AOSD.
This is a randomized single-blind comparative parallel group study of the efficacy and safety of canakinumab biosimilar GNR-086 (JSC \"GENERIUM\", Russi…
The purpose of this trial is to investigate the efficacy of the treatment with canakinumab in participants with Adult-onset Still's Disease (AOSD) and active jo…